Clostridioides difficile and colorectal cancer: a dangerous liaison

Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):985-988. doi: 10.1097/MEG.0000000000002615. Epub 2023 Jul 17.

Abstract

Many colorectal diseases depend on complex interactions between several pathophysiological factors, including the intestinal microbiota. In recent years, the widespread use of antibiotics has been recognized as a main cause of intestinal dysbiosis and a favouring factor for Clostridioides difficile infection. The latter, in addition, causes infectious diarrhoea, pseudomembranous colitis, and toxic megacolon by means of its toxins (A and, especially, B), is characterized by frequent relapses; thus, its persistence in a host may be long-lasting. Based on recent experimental evidence, here we analyse the possibility that, similarly to other bacteria, Clostridioides difficile may be considered a potential carcinogen for colorectal cancer.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides
  • Clostridioides difficile*
  • Clostridium Infections* / diagnosis
  • Clostridium Infections* / drug therapy
  • Clostridium Infections* / epidemiology
  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / epidemiology
  • Colorectal Neoplasms* / etiology
  • Enterocolitis, Pseudomembranous* / microbiology
  • Humans

Substances

  • Anti-Bacterial Agents